HPTN & ACTG Joint Plenary - 2024 HPTN Annual Meeting

0:00 (Welcome)
2:39 (LATITUDE: Comparing a Monthly Injectable ART to Daily Oral Drugs)
15:51 (Integrase Resistance: How to Manage in Less than Perfectly Monitored Populations)
33:52 (INSTI Resistance in the Setting of CAB-LA PrEP)
47:19 (Questions and Answers)
1:15:45 (Reaching Populations with High HIV Incidence and Limited Access to Services)
1:40:04 (Questions and Answers)